Krystal Biotech, INC Form 4 insider transactions
NASDAQ
Krystal Biotech's CEO, Krish Krishnan, reports the surrender of shares for tax withholding upon vesting of restricted stock.
NASDAQ
Form 4: Krystal Biotech's Chief Accounting Officer Executes Stock Options and Sales Under 10b5-1 Plan
Kathryn Romano, Chief Accounting Officer of Krystal Biotech, Inc., reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.